Nov 11, 2024

Abstract 4148214: Missing the Point: Readability Analysis of Online Patient Information for Cardiac Amyloidosis

Read more

Nov 09, 2024

Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments

Read more

Sep 19, 2024

A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis (AQUARIUS)

Read more

Jun 23, 2024

RNA Interference Therapeutics for Hereditary Amyloidosis: A Narrative Review of Clinical Trial Outcomes and Future Directions

Read more

Apr 23, 2024

Between hope and reality: treatment of genetic diseases through nucleic acid-based drugs

Read more

Apr 09, 2024

Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures

Read more

Jan 18, 2024

Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy

Read more

Jan 03, 2024

Development and Testing of a Chronic-Disease Patient Experience Mapping Toolbox

Read more

Mar 22, 2022

RNA-Targeting and Gene Editing Therapies for Transthyretin Amyloidosis

Read more

Jun 18, 2018

Features of Atrial Fibrillation in Wild-Type Transthyretin Cardiac Amyloidosis: A Systematic Review and Clinical Experience

Read more

Subscribe to